117 related articles for article (PubMed ID: 20002760)
1. Peripheral T-cell lymphoma presenting as myelofibrosis with the expression of basic fibroblast growth factor.
Kikukawa M; Umahara T; Kikawada M; Kanaya K; Sakurai H; Shin K; Mori M; Iwamoto T
Geriatr Gerontol Int; 2009 Dec; 9(4):395-8. PubMed ID: 20002760
[TBL] [Abstract][Full Text] [Related]
2. Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders.
Sayinalp N; Cinar H; Uner A; Haznedaroğlu IC; Büyükaşik Y; Göker H; Aksu S; Ozcebe OI; Karakuş S; Kirazli S; Dündar SV
Clin Lab Haematol; 2004 Aug; 26(4):265-8. PubMed ID: 15279663
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
[TBL] [Abstract][Full Text] [Related]
4. Peripheral T cell lymphoma, not otherwise specified with myelofibrosis: report of a case with review of the literature.
Sekiguchi Y; Shirane S; Shimada A; Ichikawa K; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2015; 8(4):4186-203. PubMed ID: 26097612
[TBL] [Abstract][Full Text] [Related]
5. Splenic marginal zone lymphoma presenting as myelofibrosis associated with bone marrow involvement of lymphoma cells which secrete a large amount of TGF-beta.
Matsunaga T; Takemoto N; Miyajima N; Okuda T; Nagashima H; Sato T; Terui T; Sasaki H; Ohmi N; Hirayama Y; Tamura Y; Niitsu Y
Ann Hematol; 2004 May; 83(5):322-5. PubMed ID: 15060752
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow stromal cell distribution of basic fibroblast growth factor in chronic myeloid disorders.
Yoon SY; Tefferi A; Li CY
Haematologica; 2001 Jan; 86(1):52-7. PubMed ID: 11146571
[TBL] [Abstract][Full Text] [Related]
7. [Peripheral T-cell lymphoma initially presenting as secondary myelofibrosis].
Takai K; Sanada M
Rinsho Ketsueki; 1989 Dec; 30(12):2199-204. PubMed ID: 2695663
[TBL] [Abstract][Full Text] [Related]
8. Peripheral T-cell lymphoma together with myelofibrosis with elevated plasma transforming growth factor-beta1.
Okabe S; Miyazawa K; Iguchi T; Sumi M; Takaku T; Ito Y; Kimura Y; Serizawa H; Mukai K; Ohyashiki K
Leuk Lymphoma; 2005 Apr; 46(4):599-602. PubMed ID: 16019489
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma.
Ho CL; Sheu LF; Li CY
Ann Diagn Pathol; 2003 Feb; 7(1):1-8. PubMed ID: 12616467
[TBL] [Abstract][Full Text] [Related]
11. Cell dynamics and expression of tumor necrosis factor (TNF)-alpha, interleukin-6, and TNF receptors in angioimmunoblastic lymphadenopathy-type T cell lymphoma.
Yamaguchi S; Kitagawa M; Inoue M; Tomizawa N; Kamiyama R; Hirokawa K
Exp Mol Pathol; 2000 Apr; 68(2):85-94. PubMed ID: 10716912
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis.
Martyré MC; Le Bousse-Kerdiles MC; Romquin N; Chevillard S; Praloran V; Demory JL; Dupriez B
Br J Haematol; 1997 May; 97(2):441-8. PubMed ID: 9163611
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders.
Bock O; Schlué J; Mengel M; Büsche G; Serinsöz E; Kreipe H
J Pathol; 2004 May; 203(1):609-15. PubMed ID: 15095485
[TBL] [Abstract][Full Text] [Related]
14. The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma.
Khnykin D; Troen G; Berner JM; Delabie J
J Pathol; 2006 Feb; 208(3):431-8. PubMed ID: 16353171
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow and peripheral blood changes in non-Hodgkin's lymphoma.
Lim EJ; Peh SC
Singapore Med J; 2000 Jun; 41(6):279-85. PubMed ID: 11109344
[TBL] [Abstract][Full Text] [Related]
16. Peripheral T-cell lymphoma presenting with rapidly progressing myelofibrosis.
Uehara E; Tasaka T; Matsuhashi Y; Fujita M; Tamura T; Shimoura Y; Mano S; Kuwajima M; Nagai M
Leuk Lymphoma; 2003 Feb; 44(2):361-3. PubMed ID: 12688359
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow histochemical studies of fibrogenic cytokines and their receptors in myelodysplastic syndrome with myelofibrosis and related disorders.
Yoon SY; Li CY; Lloyd RV; Tefferi A
Int J Hematol; 2000 Oct; 72(3):337-42. PubMed ID: 11185990
[TBL] [Abstract][Full Text] [Related]
18. Osteosclerosis in advanced chronic idiopathic myelofibrosis is associated with endothelial overexpression of osteoprotegerin.
Bock O; Loch G; Schade U; Büsche G; Wasielewski R; Wiese B; Kreipe H
Br J Haematol; 2005 Jul; 130(1):76-82. PubMed ID: 15982347
[TBL] [Abstract][Full Text] [Related]
19. Expression of basic fibroblast growth factor and its receptor by fibroblast, macrophages and mast cells in hypertrophic scar.
Akimoto S; Ishikawa O; Iijima C; Miyachi Y
Eur J Dermatol; 1999; 9(5):357-62. PubMed ID: 10417437
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin's disease and peripheral T-cell lymphoma: composite lymphoma with evidence of Epstein-Barr virus infection.
Niedobitek G; Baumann I; Brabletz T; Lisner R; Winkelmann C; Helm G; Kirchner T
J Pathol; 2000 Aug; 191(4):394-9. PubMed ID: 10918214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]